and Stores, 1970; Jensen and Olesen, 1970; Ralston, Snaith, and Hirley, 1970) . It is unlikely that the differences between these results and those of Reynolds (1967) and Neubauer (1970) can be explained by shorter exposure to folic acid; Neubauer (1970) noticed mental improvement in younger children from 5 to 8 weeks after starting folic acid and the adults reported by Grant and Stores (1970) received folic acid for 6 months with no effect. We have now shown that normal levels of folate are achieved very rapidly in both the red cells and serum when folic acid is given to folate-deficient patients on anticonvulsants; these results taken together with the lack of behavioural response in the controlled trials suggests that, in this context, folic acid has little direct effect on mental function. The possibility remains that the very slow deterioration in mental performance noted in some epileptics might be related to chronic folic acid deficiency.
We also confirmed the results of the controlled trials in adults (Grant and Stores, 1970; Jensen and Olesen, 1970; Ralston et al., 1970) in not showing an increase in fits due to folic acid. Folic acid has undoubtedly provoked fits in some individuals (Chanarin et al., 1960; Reynolds, 1967) (MRC Report, 1953) . Tetracycline, chloramphenicol, and erythromycin have all been recommended (MRC Report, 1953; Christie, 1969; Bass et al., 1969) .
Trimethorprim/sulphamethoxazole is a bactericidal combination active in vitro against Bordetella pertussis (Bushby, 1969) (Preston, 1965) . Sensitivity tests were carried out by the disc diffusion method against tetracycline (25 utg per disc) and trimethoprim/sulphamethoxazole (2 5 ,ug and 50 jug, respectively, per disc).
Results
Patients studied. The total number of children satisfying criteria for inclusion in the trial was 88, with equal numbers in each treatment group. Ages varied widely, but 90% were less than 5 years old. Details of the age-sex distribution are given in Table I . Only 12 children had been immunized, 3 in the tetracycline group and 8 in the trimethopnrm /sulphamethoxazole group; in addition, one child in the tetracycline group had been partially immunized. Bacteriology. Bord. pertussis was isolated from 62 patients at the first visit; the other 26 patients were included in the study as they had a typical clinical history, typical cough, and a relative and absolute lymphocytosis. Of the 62 isolates, 50 (80 * 6%) possessed factors 1, 2, and 3; 10 (16 -1%) had factors 1 and 2 only, while 2 (3 2%) had factors 1 and 3 only. All 12 previously immunized Total number of patients 26 21 children were infected with strains possessing all three factors. All strains of Bord. pertussis were sensitive to both chemotherapeutic agents. No strains were isolated at second attendance of patients.
Duration of symptoms. Of the 88 patients in the study, 56 had a cough for less than 7 days: 34 of these were in the trimethoprim/sulphamethoxazole group and 21 in the tetracycline group. In the former group the mean duration of cough before attendance was 5 6 days (SD 2 7) and in the latter group it was 6 8 days (SD 3 8). This difference is not significant (P >0 05). Patients from whom Bord. pertussis was isolated were seen slightly earlier than those with negative cultures, the mean duration of cough being 5 8 days (SD 3 0) and 6 9 days (SD 3 9), respectively. Again, this difference does not reach a level of statistical significance (P >0 05).
Effect of treatment. Out of the 88 patients, only 66 returned for follow-up: of these, 33 were judged to have improved, 27 remained the same, and 6 had deteriorated. Details are given in Table  II and it can be seen that there is little difference between the 2 groups.
When, however, only those patients with a history of cough for less than 7 days were considered (Table III) , it was found that those in the trimethoprim/sulphamethoxazole group appeared to do slightly better than those in the tetracycline group. With the small numbers in each group, the differences do not reach a level of statistical significance (P >0.05). The mean duration of cough before treatment did not differ significantly between these 2 groups, nor was there any difference in results between patients with or without a positive isolation of Bord. pertussis.
Discussion
The present trial was a direct comparison between tetracycline and trimethoprim/sulphamethoxazole. We were not concerned with the value of chemotherapeutic treatment per se, and thus no untreated control group was included.
It is known that chemotherapy is only effective in the early stages of pertussis. One major difficulty in the treatment of the disease is that by the time the child presents for treatment-seldom if ever before the cough has developed-the pathology of the illness is already well advanced. Nevertheless, tetracycline is known to be of some benefit (MRC Report, 1953) , and our results indicate that there may be a slight advantage of trimethoprim/sulphamethoxazole over tetracycline, but only in children with a history of less than 7 days' cough. Summary A trial of trimethoprim/sulphamethoxazole against tetracycline as a treatment for pertussis was made in 88 Nigerian children. Results were slightly in favour of trimethoprim/sulphamethoxazole when treatment was instituted within 7 days of the onset of cough, but not significantly so. 
